research

FactSet Research Systems' Third-Quarter Earnings Beat Estimates

FactSet Research Systems' Third-Quarter Earnings Beat Estimates

On Tuesday, FactSet Research Systems Inc. (NYSE: FDS), announced its financial results for the third quarter of fiscal 2018.“We are making progress integrating and cross selling our acquisitions resulting in important wins this quarter, partic..

John Wiley & Sons Beat on Q4 Earnings

John Wiley & Sons Beat on Q4 Earnings

On Tuesday, John Wiley & Sons, Inc. (NYSE: JW.A) announced its financial results for the fourth quarter for fiscal 2018. Shares of the global research and education company remained unchanged in premarket trading Tuesday after reaching $68.9 per..

Campbell's Shares Plummet After CEO Resigns and Weaker Outlook

Campbell's Shares Plummet After CEO Resigns and Weaker Outlook

Campbell’s Soup Company (NYSE: CPB) shares plummeted on Friday after its Chief Executive Officer Denise Morrison abruptly resigned and its weaker-than-expected fiscal outlook. Shares fell by 11.3 percent after the opening bell.Morrison served ..

Toyota Partners with Luminar on the Newest Version of Autonomous Platform

Toyota Partners with Luminar on the Newest Version of Autonomous Platform

On Wednesday, Toyota Research Institute, which is Toyota Motor Corp (NYSE: TM) research arm, announced that it would partner with Luminar on its newest version of autonomous platform.Luminar was founded five years ago, and began to develop a new LiD..

Twitter to Test 280 Characters Tweet

Twitter to Test 280 Characters Tweet

Twitter Inc (NYSE: TWTR) on Wednesday announced to expand the length of a tweet to 280 characters from 140 characters, a move that aims to attract more users.The social media company said in a blog post that the new feature will start with &ldq..

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma A/S (NASDAQ: ASND) shares jumped over 40% in premarket on Friday following the news that its competitor, Versartis Inc. (NASDAQ: VSAR) late-stage clinical trial missed its primary endpoint. Versartis shares plummeted down over 86 per..

IBM invests $240 for AI research with MIT

IBM invests $240 for AI research with MIT

International Business Machines Corp. (NYSE: IBM) and Massachusetts Institute of Technology announced on Thursday that the two plan for 10 year, $240 million investment to create the MIT-IBM Watson AI Lab. The lab’s purpose is to research fund..